{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Bradley Beach",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75929",
      "recalling_firm": "Jersey Shore Supplements, LLC",
      "address_1": "705 Brinley Ave",
      "address_2": "N/A",
      "postal_code": "07720-1054",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "New Jersey and  Maryland.",
      "recall_number": "D-0473-2017",
      "product_description": "SLIMFIT X capsules, packaged in a 60-cont bottle",
      "product_quantity": "150 bottles",
      "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.",
      "recall_initiation_date": "20161209",
      "center_classification_date": "20170213",
      "termination_date": "20201117",
      "report_date": "20170222",
      "code_info": "All lots and all expiration dates.",
      "more_code_info": ""
    }
  ]
}